Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
J Infect Chemother ; 20(3): 163-8, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24508422

ABSTRACT

Although there are many studies about catheter related infection in industrialized countries, very few have analyzed it in emerging countries. The aim of our study was to determine the incidence, microbiological profile and risk factors for catheter-related bloodstream infection (CRBSI) in a Tunisian medical intensive care unit. Over eight months (1 January 2012-30 August 2012) a prospective, observational study was performed in an 18-bed medical surgical intensive care unit at Tunis military hospital. Patients who required central venous catheter (CVC) placement for a duration greater than 48 h were included in the study. Two hundred sixty patients, with a total of 482 CVCs were enrolled. The mean duration of catheterization was 9.6 ± 6.2 days. The incidence for CRBSI and catheter colonization (CC) was 2.4 and 9.3 per 1000 catheter days, respectively. Risk factors independently associated with CRBSI were diabetes mellitus, long duration of catheterization, sepsis at insertion and administration of one or more antibiotics before insertion. The mortality rate among the CRBSI group was 21.8%. The predominant microorganisms isolated from CRBSI and CC episodes were Gram negative bacilli. All Gram negative organisms isolated among dead patients in CRBSI group were Extensive Drug Resistant (XDR). In our study the mortality rate among patients with CRBSI was high despite a low incidence of CRBSI. This high rate can be explained by the high-virulent status of Gram negative bacteria involved in CRBSI.


Subject(s)
Bacteremia/epidemiology , Bacteremia/microbiology , Catheter-Related Infections/epidemiology , Catheter-Related Infections/microbiology , Intensive Care Units/statistics & numerical data , Bacteria/isolation & purification , Candidemia/epidemiology , Candidemia/microbiology , Catheters, Indwelling/microbiology , Female , Fungi/isolation & purification , Humans , Male , Middle Aged , Prospective Studies , Risk Factors
2.
Crit Care ; 17(5): R255, 2013 Oct 24.
Article in English | MEDLINE | ID: mdl-24156734

ABSTRACT

INTRODUCTION: Procalcitonin (PCT) biomarker is suggested to tailor antibiotic therapy in the medical intensive care unit (ICU) but studies in perioperative medicine are scarce. The aim of this study was to determine whether PCT reported thresholds are associated with the initial treatment response in perioperative septic shock secondary to intra-abdominal infection. METHODS: This single ICU, observational study included patients with perioperative septic shocks secondary to intra-abdominal infection. Demographics, PCT at days 0, 1, 3, 5, treatment response and outcome were collected. Treatment failure included death related to the initial infection, second source control treatment or a new onset intra-abdominal infection. The primary endpoint was to assess whether PCT thresholds (0.5 ng/ml or a drop from the peak of at least 80%) predict the initial treatment response. RESULTS: We included 101 consecutive cases. Initial treatment failed in 36 patients with a subsequent mortality of 75%. Upon admission, PCT was doubled when treatment ultimately failed (21.7 ng/ml ± 38.7 vs. 41.7 ng/ml ± 75.7; P = 0.04). Although 95% of the patients in whom PCT dropped down below 0.5 ng/ml responded to treatment, 50% of the patients in whom PCT remained above 0.5 ng/ml also responded successfully to treatment. Moreover, despite a PCT drop of at least 80%, 40% of patients had treatment failure. CONCLUSIONS: In perioperative intra-abdominal infections with shock, PCT decrease to 0.5 ng/ml lacked sensitivity to predict treatment response and its decrease of at least 80% from its peak failed to accurately predict treatment response. Studies in perioperative severe infections are needed before using PCT to tailor antibiotic use in this population.


Subject(s)
Anti-Infective Agents/therapeutic use , Calcitonin/blood , Intraabdominal Infections/drug therapy , Protein Precursors/blood , Shock, Septic/drug therapy , Aged , Biomarkers/blood , C-Reactive Protein/metabolism , Calcitonin Gene-Related Peptide , Female , Humans , Intraabdominal Infections/blood , Male , Predictive Value of Tests , Shock, Septic/blood , Treatment Outcome
3.
Saudi J Kidney Dis Transpl ; 21(6): 1157-64, 2010 Nov.
Article in English | MEDLINE | ID: mdl-21060199

ABSTRACT

End-stage renal disease (ESRD) is known to be an important risk factor for cardiac operations performed with cardiopulmonary bypass. We investigated the influence of preoperative status on perioperative mortality and morbidity. We retrospectively analyzed data from 26 patients with ESRD, who were on maintenance dialysis and underwent a cardiac surgical procedure bet-ween 2000 and 2007. Of them, 61.5% of the patients had isolated coronary artery bypass grafting (CABG) and 38.5% had replacement or reconstruction of one or two valves. The perioperative mortality rate was 26% with five deaths occurring in patients undergoing CABG procedure. We found CABG procedure, being female and left ventricular (LV) function < 30% to be associated with a higher relative risk for perioperative death. In conclusion, our data suggest that both indi-cations and referral for surgical intervention for coronary artery disease may be delayed in pa-tients who have ESRD, contributing to the relatively high perioperative mortality.


Subject(s)
Coronary Artery Bypass/statistics & numerical data , Heart Valve Prosthesis Implantation/statistics & numerical data , Hospitals, Military/statistics & numerical data , Kidney Failure, Chronic/therapy , Renal Dialysis/statistics & numerical data , Adult , Aged , Coronary Artery Bypass/adverse effects , Coronary Artery Bypass/mortality , Female , Heart Valve Prosthesis Implantation/adverse effects , Heart Valve Prosthesis Implantation/mortality , Humans , Kidney Failure, Chronic/mortality , Male , Middle Aged , Renal Dialysis/adverse effects , Renal Dialysis/mortality , Retrospective Studies , Risk Assessment , Risk Factors , Sex Factors , Time Factors , Treatment Outcome , Tunisia/epidemiology , Ventricular Function, Left
SELECTION OF CITATIONS
SEARCH DETAIL